Xiangrong Dai

921 total citations
24 papers, 579 citations indexed

About

Xiangrong Dai is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Xiangrong Dai has authored 24 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Xiangrong Dai's work include Platelet Disorders and Treatments (9 papers), Venomous Animal Envenomation and Studies (7 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Xiangrong Dai is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Venomous Animal Envenomation and Studies (7 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Xiangrong Dai collaborates with scholars based in China, United States and Canada. Xiangrong Dai's co-authors include Benjamin Xiaoyi Li, Xi Lei, Heyu Ni, Tyler W. Stratton, Xiaohong Xu, Naadiya Carrim, Miguel A. D. Neves, Jianhua Xu, Thomas McKeown and Pingguo Chen and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Xiangrong Dai

23 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangrong Dai China 12 211 134 133 105 83 24 579
Emily J. Welch United States 8 217 1.0× 248 1.9× 71 0.5× 193 1.8× 24 0.3× 9 694
Sven Danckwardt Germany 17 185 0.9× 741 5.5× 74 0.6× 113 1.1× 67 0.8× 30 1.1k
Xun Xie Sweden 16 98 0.5× 272 2.0× 44 0.3× 397 3.8× 20 0.2× 21 928
Giorgia Manni Italy 12 96 0.5× 327 2.4× 52 0.4× 191 1.8× 31 0.4× 18 718
M. Anna Kowalska United States 13 295 1.4× 156 1.2× 83 0.6× 106 1.0× 16 0.2× 18 578
Amanda E. Au Australia 11 85 0.4× 203 1.5× 23 0.2× 112 1.1× 14 0.2× 16 470
Nathan Ezov Israel 12 98 0.5× 73 0.5× 57 0.4× 51 0.5× 25 0.3× 20 392
D Pasotti Italy 8 61 0.3× 97 0.7× 129 1.0× 196 1.9× 14 0.2× 23 487
Yasuko Soejima Japan 13 82 0.4× 244 1.8× 49 0.4× 144 1.4× 33 0.4× 20 534

Countries citing papers authored by Xiangrong Dai

Since Specialization
Citations

This map shows the geographic impact of Xiangrong Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangrong Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangrong Dai more than expected).

Fields of papers citing papers by Xiangrong Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangrong Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangrong Dai. The network helps show where Xiangrong Dai may publish in the future.

Co-authorship network of co-authors of Xiangrong Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangrong Dai. A scholar is included among the top collaborators of Xiangrong Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangrong Dai. Xiangrong Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lü, Shun, Zhiwei Chen, Jiuwei Cui, et al.. (2023). Efficacy and Safety of Anti–Programmed Death-Ligand 1 Monoclonal Antibody Socazolimab With Carboplatin and Etoposide for Extensive-Stage SCLC: Results From the Phase 1b Clinical Trial. JTO Clinical and Research Reports. 4(4). 100478–100478. 2 indexed citations
4.
Chan, Brandon, Wing‐Yan Wong, Magnolia Muk‐Lan Lee, et al.. (2023). Isolation and characterization of ZK002, a novel dual function snake venom protein from Deinagkistrodon acutus with anti-angiogenic and anti-inflammatory properties. Frontiers in Pharmacology. 14. 1227962–1227962. 6 indexed citations
5.
Li, Rui, Zheng Ma, Xinwei Li, et al.. (2022). Anfibatide alleviates inflammation and apoptosis via inhibiting NF-kappaB/NLRP3 axis in ischemic stroke. European Journal of Pharmacology. 926. 175032–175032. 15 indexed citations
6.
7.
8.
Adili, Reheman, et al.. (2021). Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice. Clinical and Applied Thrombosis/Hemostasis. 27. 2975200014–2975200014. 1 indexed citations
9.
Li, Jing, Kyungho Kim, Joyce Chiu, et al.. (2019). Platelet Protein Disulfide Isomerase Promotes Glycoprotein Ibα–Mediated Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions. Circulation. 139(10). 1300–1319. 80 indexed citations
10.
Li, Rui, et al.. (2019). Anfibatide Preserves Blood–Brain Barrier Integrity by Inhibiting TLR4/RhoA/ROCK Pathway After Cerebral Ischemia/Reperfusion Injury in Rat. Journal of Molecular Neuroscience. 70(1). 71–83. 23 indexed citations
11.
Zheng, Liang, et al.. (2017). Therapeutic Efficacy of Anfibatide in a Murine Model of Thrombotic Thrombocytopenic Purpura (TTP). American Journal of Clinical Pathology. 147(suppl_2). S153–S153. 1 indexed citations
12.
13.
Xu, Xiaohong, Naadiya Carrim, Miguel A. D. Neves, et al.. (2016). Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies. Thrombosis Journal. 14(S1). 29–29. 149 indexed citations
14.
15.
Guo, Yugang, Jing Wu, Wei Chen, et al.. (2015). Balancing the Expression and Production of a Heterodimeric Protein: Recombinant Agkisacutacin as a Novel Antithrombotic Drug Candidate. Scientific Reports. 5(1). 11730–11730. 11 indexed citations
16.
Zheng, Liang, et al.. (2015). Therapeutic Efficacy of Anfibatide in a Murine Model of Thrombotic Thrombocytopenic Purpura. Blood. 126(23). 659–659. 1 indexed citations
17.
Ji, Haixia, Jingjing Duan, Zhirong Jia, et al.. (2013). The Synthetic Melanocortin (CKPV)2 Exerts Anti-Fungal and Anti-Inflammatory Effects against Candida albicans Vaginitis via Inducing Macrophage M2 Polarization. PLoS ONE. 8(2). e56004–e56004. 12 indexed citations
18.
Lei, Xi, Reheman Adili, Yan Hou, et al.. (2013). Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis. Thrombosis and Haemostasis. 112(2). 279–289. 105 indexed citations
19.
Hou, Yan, Xi Lei, Benjamin Xiaoyi Li, et al.. (2013). The First In Vitro and In Vivo Assessment Of Anfibatide, a Novel Glycoprotein Ib Antagonist, In Mice and In a Phase I Human Clinical Trial. Blood. 122(21). 577–577. 11 indexed citations
20.
Dai, Xiangrong, Juanjuan Liu, Xianghong Li, et al.. (2012). An indirect sandwich ELISA for the determination of agkisacutacin in human serum: Application to pharmacokinetic study in Chinese healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis. 70. 396–400. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily J. Welch Breakdown of academic impact, for papers by Sven Danckwardt Breakdown of academic impact, for papers by Xun Xie Breakdown of academic impact, for papers by Giorgia Manni Breakdown of academic impact, for papers by M. Anna Kowalska Breakdown of academic impact, for papers by Amanda E. Au Breakdown of academic impact, for papers by Nathan Ezov Breakdown of academic impact, for papers by D Pasotti Breakdown of academic impact, for papers by Yasuko Soejima
Rankless by CCL
2026